Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Percheron Therapeutics ( (AU:PER) ) is now available.
Percheron Therapeutics Limited has announced that Powerhouse Ventures Limited has ceased to be a substantial holder in the company as of June 26, 2025. This change involved the sale of 6,459,495 fully paid ordinary shares for a consideration of $78,502.24. The announcement indicates a significant shift in the shareholding structure of Percheron Therapeutics, potentially impacting its market positioning and stakeholder dynamics.
The most recent analyst rating on (AU:PER) stock is a Buy with a A$0.24 price target. To see the full list of analyst forecasts on Percheron Therapeutics stock, see the AU:PER Stock Forecast page.
More about Percheron Therapeutics
Average Trading Volume: 2,513,005
Technical Sentiment Signal: Sell
Current Market Cap: A$9.79M
See more data about PER stock on TipRanks’ Stock Analysis page.